From: Therapeutic potential of heterocyclic pyrimidine scaffolds
S. no | Pathogens | a29 | a30 | Bacitracin | Ciprofloxacin |
---|---|---|---|---|---|
1 | Citrobacter sp. | 37.16 ± 0.15 | 28.66 ± 0.15 | 0.00 ± 0.00 | 19.62 ± 0.18 |
2 | Escherichia coli | 36.66 ± 0.15 | 27.83 ± 0.20 | 0.00 ± 0.00 | 0.00 ± 0.00 |
3 | Klebsiella sp. | 32.50 ± 0.13 | 25.50 ± 0.27 | 0.00 ± 0.00 | 20.25 ± 0.16 |
4 | Proteus mirabilis | 28.66 ± 0.25 | 23.33 ± 0.17 | 0.00 ± 0.00 | 18.25 ± 0.16 |
5 | Pseudomonas aeruginosa | 30.66 ± 0.12 | 27.83 ± 0.27 | 0.00 ± 0.00 | 34.25 ± 0.16 |
6 | S. parathyphi A | 34.66 ± 0.12 | 24.50 ± 0.12 | 0.00 ± 0.00 | 27.75 ± 0.16 |
7 | S. parathyphi B | 32.50 ± 0.13 | 27.83 ± 0.20 | 0.00 ± 0.00 | 27.63 ± 0.18 |
8 | Salmonella typhi | 29.50 ± 0.25 | 19.66 ± 0.11 | 0.00 ± 0.00 | 20.25 ± 0.16 |
9 | S. typhimurium | 34.66 ± 0.12 | 23.33 ± 0.17 | 0.00 ± 0.00 | 18.75 ± 0.31 |
10 | Shigella boydii | 37.50 ± 0.07 | 28.66 ± 0.25 | 0.00 ± 0.00 | 17.75 ± 0.16 |
11 | Shigella flexneri | 35.66 ± 0.08 | 25.50 ± 0.27 | 0.00 ± 0.00 | 27.63 ± 0.18 |
12 | Shigella sonnei | 32.50 ± 0.13 | 37.50 ± 0.07 | 0.00 ± 0.00 | 21.75 ± 0.16 |
13 | Staphylococcus aureus | 37.50 ± 0.07 | 32.50 ± 0.13 | 26.75 ± 0.84 | 18.13 ± 0.48 |
14 | Streptococcus faecalis | 38.50 ± 0.12 | 35.66 ± 0.08 | 0.00 ± 0.00 | 0.00 ± 0.00 |